Skip to main content

NYSE:RELX - Relx Stock Price Target and Predictions

  • Consensus Rating: Buy
  • Consensus Price Target: $0.00
  • Forecasted Upside: -100.00 %
  • Number of Analysts: 11
  • Breakdown:
  • 0 Sell Ratings
  • 5 Hold Ratings
  • 6 Buy Ratings
  • 0 Strong Buy Ratings
$26.35
▲ +0.6 (2.33%)
1 month | 3 months | 12 months
Get New Relx Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for RELX and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for RELX

i We calculate consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). Our consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. Our consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
$0.00
▼ -100.00% Downside Potential
This price target is based on 11 analysts offering 12 month price targets for Relx in the last 3 months. The average price target is $0.00, with a high forecast of $0.00 and a low forecast of $10,000,000.00. The average price target represents a -100.00% upside from the last price of $26.35.

Buy

The current consensus among 11 contributing investment analysts is to buy stock in Relx. This rating has held steady since December 2019, when it changed from a Hold consensus rating.

Past Monthly Recommendations

Move your mouse over past months for details

  • 0 strong buy ratings
  • 1 buy ratings
  • 1 hold ratings
  • 0 sell ratings
11/23/2019
  • 0 strong buy ratings
  • 1 buy ratings
  • 1 hold ratings
  • 0 sell ratings
2/21/2020
  • 0 strong buy ratings
  • 4 buy ratings
  • 2 hold ratings
  • 0 sell ratings
5/21/2020
  • 0 strong buy ratings
  • 5 buy ratings
  • 4 hold ratings
  • 0 sell ratings
8/19/2020
  • 0 strong buy ratings
  • 6 buy ratings
  • 4 hold ratings
  • 0 sell ratings
11/17/2020
  • 0 strong buy ratings
  • 6 buy ratings
  • 4 hold ratings
  • 0 sell ratings
2/15/2021
  • 0 strong buy ratings
  • 5 buy ratings
  • 5 hold ratings
  • 0 sell ratings
4/16/2021
  • 0 strong buy ratings
  • 6 buy ratings
  • 5 hold ratings
  • 0 sell ratings
5/16/2021

Latest Recommendations

  • 0 strong buy ratings
  • 6 buy ratings
  • 5 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
4/23/2021BarclaysReiterated RatingOverweightLow
i
4/23/2021Credit Suisse GroupReiterated RatingOutperformLow
i
3/1/2021Deutsche Bank AktiengesellschaftReiterated RatingHoldLow
i
2/19/2021Morgan StanleyReiterated RatingOverweightLow
i
2/12/2021BarclaysReiterated RatingOverweightLow
i
1/29/2021BarclaysReiterated RatingOverweightLow
i
1/12/2021Berenberg BankReiterated RatingHoldLow
i
12/9/2020Kepler Capital MarketsUpgradeHold ➝ BuyLow
i
12/8/2020JPMorgan Chase & Co.Reiterated RatingOverweightLow
i
10/23/2020BarclaysReiterated RatingOverweightLow
i
10/23/2020UBS GroupReiterated RatingNeutralLow
i
10/23/2020Societe GeneraleReiterated RatingBuyLow
i
7/30/2020Berenberg BankReiterated RatingHoldMedium
i
7/15/2020UBS GroupReiterated RatingNeutralLow
i
7/7/2020BarclaysReiterated RatingOverweightLow
i
6/29/2020Berenberg BankReiterated RatingHoldLow
i
6/24/2020ABN AmroDowngradeBuy ➝ HoldMedium
i
6/16/2020InvestecUpgradeSell ➝ HoldLow
i
4/9/2020JPMorgan Chase & Co.Reiterated RatingOverweightLow
i
3/12/2020CSFBReiterated RatingOutperformHigh
i
3/12/2020Credit Suisse GroupReiterated RatingOutperformHigh
i
3/5/2020UBS GroupUpgradeSell ➝ NeutralLow
i
2/14/2020Berenberg BankDowngradeBuy ➝ HoldLow
i
1/21/2020CitigroupUpgradeNeutral ➝ BuyLow
i
2/13/2019Deutsche Bank AktiengesellschaftDowngradeBuy ➝ HoldLow
i
12/6/2018BNP ParibasUpgradeUnderperform ➝ OutperformLow
i
9/24/2018BarclaysUpgradeEqual Weight ➝ OverweightLow
i
2/12/2018BarclaysDowngradeOverweight ➝ Equal WeightLow
i
2/9/2018Deutsche Bank AktiengesellschaftUpgradeHold ➝ BuyLow
i
1/31/2018BNP ParibasDowngradeNeutral ➝ UnderperformLow
i
1/22/2018Morgan StanleyDowngradeOverweight ➝ Equal WeightLow
i
1/10/2018The Goldman Sachs GroupUpgradeNeutral ➝ BuyLow
i
6/14/2017ABN AmroUpgradeHold ➝ BuyLow
i
5/15/2017UBS GroupDowngradeBuy ➝ NeutralN/A
i
2/21/2017Jefferies Financial GroupUpgradeHold ➝ BuyN/A
i
11/22/2016Credit Suisse GroupUpgradeNeutral ➝ OutperformN/A
i
11/11/2016Deutsche Bank AktiengesellschaftReiterated RatingHoldN/A
i
10/28/2016Deutsche Bank AktiengesellschaftReiterated RatingHoldN/A
i
10/28/2016BarclaysReiterated RatingOverweightN/A
i
10/25/2016Bank of AmericaInitiated CoverageBuyN/A
i
7/26/2016JPMorgan Chase & Co.Reiterated RatingOverweightN/A
i
7/15/2016Deutsche Bank AktiengesellschaftDowngradeBuy ➝ HoldN/A
i
7/15/2016UBS GroupInitiated CoverageBuyN/A
i
(Data available from 5/16/2016 forward)
Relx logo
RELX PLC provides information-based analytics and decision tools for professional and business customers in North America, Europe, and internationally. It operates through four segments: Scientific, Technical & Medical; Risk; Legal; and Exhibitions. The Scientific, Technical & Medical segment provides information and analytics that help institutions and professionals to progress in science and advance healthcare. The Risk segment offers information-based analytics and decision tools that combine public and industry specific content with technology and algorithms to assist clients in evaluating and predicting risk. The Legal segment provides legal, regulatory, and business information and analytics that help customers in decision-making, as well as enhance the productivity. The Exhibitions segment is involved in the events business. The company was formerly known as Reed Elsevier PLC and changed its name to RELX PLC in July 2015. The company was incorporated in 1903 and is headquartered in London, the United Kingdom.
Read More

Today's Range

Now: $26.35
$26.07
$26.38

50 Day Range

MA: $26.25
$25.10
$27.13

52 Week Range

Now: $26.35
$19.52
$27.15

Volume

626,090 shs

Average Volume

607,654 shs

Market Capitalization

$50.89 billion

P/E Ratio

22.14

Dividend Yield

3.65%

Beta

0.72

Frequently Asked Questions

What sell-side analysts currently cover shares of Relx?

The following Wall Street sell-side analysts have issued research reports on Relx in the last year: ABN Amro, Barclays PLC, Berenberg Bank, Credit Suisse Group AG, Deutsche Bank Aktiengesellschaft, Investec, JPMorgan Chase & Co., Kepler Capital Markets, Morgan Stanley, Societe Generale, UBS Group AG, and Zacks Investment Research.
View the latest analyst ratings for RELX.

What is the current price target for Relx?

0 Wall Street analysts have set twelve-month price targets for Relx in the last year. has the lowest price target set, forecasting a price of $10,000,000.00 for Relx in the next year.
View the latest price targets for RELX.

What is the current consensus analyst rating for Relx?

Relx currently has 5 hold ratings and 6 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Buy." A "buy" rating indicates that analysts believe RELX will outperform the market and that investors should add to their positions of Relx.
View the latest ratings for RELX.

What other companies compete with Relx?

How do I contact Relx's investor relations team?

Relx's physical mailing address is 1-3 STRAND, LONDON X0, WC2N 5JR. The technology company's listed phone number is 44-20-7166-5500 and its investor relations email address is [email protected] The official website for Relx is www.relx.com.